Click Here For More Information About Our Research & Development Programs
BREAKING NEWS
Coming Soon
Address
Glycemic Research Institute®
Capitol Hill
300 New Jersey Ave. Northwest Suite 900
Washington, D.C., 20001
Phone
Coming Soon!
BURGER KING RECEIVES 2008-2009 KID FRIENDLY “PRODUCT OF THE YEAR”
​
Dr. Ann de Wees Allen
Chief of Biomedical Research & Chief Science Officer
Director of IIRB Board Approved Human In Vivo Clinical Trials
Director: Nutritional Neuroscience in Coding Foods & Beverages
Association of Clinical Research Professionals (ACRP):
ACRP Member for 19 Years: 2005- Present
Background Clinical Research Projects
Glycoside Metabolic Research: Monk Fruit/Stevia
​
Glycemic Index & Load
​
Obesity & Diabetes: Board Approved Clinical Trials in Adults & Children
​
Sickle Cell & Thalassemia: Joint Partner Researchers: John's Hopkins Dept. of Genetics & Dr. Randell Maxey MD, PhD, President of the National Medical Association.
Dr. Allen Presented at the United Nations General Assembly.
​
Microgravity in Space Flight: NASA
​
Sports Performance Beverages: Research & Development: Professional Sport Performance: Metabolic Fuel in Sports Science: NSF Approved.
Research Development of Brain-Friendly Fuel & Sport-fuel in the field of Brain Energetics (based on Board Approved Human In Vivo Clinical Trials)​
Gut-Brain Axis: Neural Coding
Director: Nutritional Neuroscience in Coding Foods & Beverages
Metabolic GPS Systems in the Gut Brain Axis: Developing Alternatives to High Glycemic Sugars, Sweeteners, non-metabolic & Artificial Sweeteners:
Plant-Based (GRAS) Biomolecules as Zwitterions; Crossing the Blood-Brain Barrier (BBB) in Humans: Core Vector Compounds; including L-Arginine & Sweet Flavor Systems (Dr. Allen- Patent Received)
​
Research Diameters & Quantifications:
-
IRBB Board Approved Human In Vivo Clinical Trials
-
LC-MS; Liquid Chromatography Mass Spectrophotometer; Design & Identification of Viable Plant-Based Biomolecules: TIME OF FLIGHT LCMS: Research conducted by independent laboratory for Dr. Allen Core Compounds
-
LC-MS Identification & Utilization of brain & blood-sugar appropriate sugars, sweeteners, glycosides, and plant metabolics in the design of blood-sugar, diabetic, obesity, and kid-friendly natural sweet-systems for foods & beverages (with clinical research)
​​
Awards, Patents, Technology
Newsweek Magazine Newsweek Media: Dr. Ann de Wees Allen® named as one of the "Top 10 Experts in the World"
Scientist generates over $1 Billion dollars in Patents &Technology
​
First Glycemic Patent Ever Awarded Worldwide:
1st Patent ever awarded on glycemic index: Pioneer of the Glycemic Index
​
Who's Who of American Inventors
​
Clinical Research Scientist Combinatorial Chemistry
​
Wall Street Journal: $300 Million dollars generated in 1st year of Patent Awarded
​
"Breakthrough Product of the Year" Success magazine​
​
Glycoside Researcher:
First Scientist to bring Monk Fruit glycosides into the United States to conduct clinical trials in humans: Metabolic Response
​
Patent Received: Neural Transport of metabolic agents entering the Blood-Brain Barrier Activating the Hypothalamic-Pituitary Axis
​
NASA: Mitigation of the Side Effects of Microgravity in Astronauts During Space Flight; Dr. Ann de Wees Allen®
​
Who's Who in Diabetes Education and Research: by the American Diabetes Association Council on Nutritional Science & Metabolism
​
Global Medical Lectures Worldwide- in Asia for 5 1/2 Years (Thalassemia- Sickle Cell): Tokyo Convention Center; Singapore, Hong Kong, Malaysia, Thailand
​
Patents in Beverage Technology: Directional Bio-coding in Humans: Downregulating adipose tissue fat storage via Lipoprotein Lipase (LPL) in coffee, tea, including any beverage.
Consultant to Professional Athletes
Consultant to:
World Powerlifting Association, Mr. Universe, Ms. Galaxy, Arnold Schwarzenegger Classic, and other world-class athletes ever
Designed & Formulated line of Sports Products: GH, Nitric Oxide, Protein Drinks, Performance Drinks (Patents Received)​
​
Formulated and Patented Nitric Oxide formula for Jordan Romero: Youngest person in the world to climb Mt. Everest at age 13
​​​
Designed Performance Product for Michael Andretti: Four-time IndyCar Champion-Formula One Champion
​
Designed Energy Products used by Bruce Springsteen on stage​
​
​
Copyright® 2024
Read More
Artificial Sweeteners/Non-metabolic Sweeteners, including foods and beverages, do not convey fuel
This is your Team section. Briefly introduce the team then add their bios below. Click here to edit.
Arnie Joseph
Chief Executive Officer
U.S Food & Drug Administration (FDA) Member, Cardiometabolic Network
Member for 9 Years: 2015- Present
U.S. Department of Health and Human Services Equity Council Agenda Services
Regional Health Equity Council 2013​
Advocacy Chairman, New York American Diabetes Association
March 2014- February 2020- 6 years in the Greater New York City Area
Assist NYS State Advocacy Directors in writing specific local market goals.
Responsible for increasing awareness and support for ADA public policy priorities around health disparities in those communities most affected by diabetes.
Chairman, Communications sub-committee- U.S. Department of Health and Human Services
Regional Health Equity Council October 2013- June 2016- Greater New York City
Read More
Arnie Joseph
Chief Executive Officer
U.S Food & Drug Administration (FDA) Member, Cardiometabolic Network
Member for 9 Years: 2015- Present
U.S. Department of Health and Human Services Equity Council Agenda Services
Regional Health Equity Council 2013​
Advocacy Chairman, New York American Diabetes Association
March 2014- February 2020- 6 years in the Greater New York City Area
Assist NYS State Advocacy Directors in writing specific local market goals.
Responsible for increasing awareness and support for ADA public policy priorities around health disparities in those communities most affected by diabetes.
Chairman, Communications sub-committee- U.S. Department of Health and Human Services
Regional Health Equity Council October 2013- June 2016- Greater New York City
Read More
Safety Guidelines for Test(s)
​
Glycemic Research Institute
-
Client Responsibility
-
Safety Guidelines for Test Food(s) Being Submitted for Clinical Trails
More About Who We Are
​Glycemic Research Institute
-
Glycemic Research Institute® conducts human In Vivo clinical studies, which is the only legal product claim substantiation accepted by the United States government, including the FDA & FTC.
-
Laws in the United States dictate that all glycemic index claims made by food or dietary supplement products require substantiation via human clinical trials (In Vivo). Documentation demonstrating the validity of clinical evidence for said claims is required by the Federal government.
-
Glycemic Research Institute® clinical trials are approved by the appropriate Review Boards, and include diabetics, non-diabetics, overweight, and obese subjects.
-
Glycemic Research Institute® conducts clinical glycemic index testing for clients in the United States, and worldwide.​
-
Glycemic Research Institute® has the highest rate of accuracy available, with specific in-real-time analytical testing methods. The typical accuracy of GI testing has a variable of 80 percent. GRI accuracy has a variable of < 2 percent.
-
Glycemic Research Institute® clinical studies include various glycemic index protocols suited to the clients needs, including studies utilizing diabetics, non-diabetics, obese, and overweight subjects. GRI can determine clinically if the product submitted:
-
Is shunted into and/or stored in adipose tissue fat cells (is fattening)
-
Exacerbates hypoglycemia, diabetes, and insulin resistant disorders
-
Is acceptable for diabetics to consume
-
Over-elevates blood glucose or insulin levels
-
Affects sports performance in athlete
CLIENT LISTING
​Glycemic Research Institute®
The following products have been submitted to the Glycemic Research Institute ® for Human In-Vivo Clinical Trials. This is a short list of products submitted to Glycemic Research Institute® for Board Approved Human In Vivo Clinical Trials.
Glycemic Research Institute
Accredited Testing
&
Certification Organization
Glycemic Research Institute
Human Nutrition & Biochemistry Division
-
Glycemic Index & Load Clinical Trials
-
Obesity Research & Clinical Trials
-
Diabetes Research & Clinical Trials
-
Adipose Fat Storage Investigations & Trials
-
Human In Vivo Clinical Trials Laboratory
-
Department of Dietary Supplements
-
Department of Foods & Beverages
-
Department of Pharmaceuticals
-
Childhood Obesity Unit Clinical Investigations & Trials Laboratory
-
Sports Physiology Laboratory
-
Department of Biological Circuitry
-
Department of Sports Performance
-
Sports Supplements & Sports Drinks
-
Clinical Investigations & Trials Laboratory
-
Food Addictions Laboratory
-
Department of Neuroscience
-
Cephalic Research Unit
-
Department of Brain Glycemic Indexing
-
Metabolic Identity of Sugars and Sweeteners
GRI Sectors & Research Specialties:
The Glycemic Research Institute® (GRI) is one of the leading global authorities in research and development in the fields of Glycemic Index and the metabolic impact of foods and beverages in humans.
GRI Sectors & Research Specialties:
The Glycemic Research Institute® (GRI) is one of the leading global authorities in research and development in the fields of Glycemic Index and the metabolic impact of foods and beverages in humans.
Glycemic Research Institute
Substantiations
Certifications
At GRI, we are proud to be a research and development organization specializing in glycemic index testing for over 30 years. Our expertise lies in FDA and FTC legal glycemic index claims. We work closely with manufacturers to clearly identify these claims on labels.
The Largest Database in the world of the metabolic effect in humans of 400+ Sugars and Sweeteners
​​Low Glycemic Index product substantiation
​​Metabolic Identity of sugars and sweeteners substantiation
BURGER KING RECEIVES 2008-2009 KID FRIENDLY “PRODUCT OF THE YEAR”
​
Claim Substantiation For:​
-
Foods
-
Meals
-
Prepared Foods Nutraceuticals
-
Pharmaceuticals and Products in Development​​
Board approved Human In-Vivo Clinical Trials
Serving the largest food and research companies in the world​​ for over 30 years.
Metabolic Impact of Foods and Beverages in Humans
Low glycemic index, diabetic response, product substantiation for Food & Nutraceutical Companies
Glycemic Research Institute
The science of the neural and metabolic response of foods and beverages in humans.
What is a Glycemic Identity Mark?
A Symbol Of Quality, Commitment, and Integrity.
The Glycemic Identity Mark (GIM) is a symbol of quality and integrity for consumable products. It is valued by manufactures, retailers, and consumers. Having a GIM symbol on a product's label validates its claim and that the product has been independently evaluated and inspected by the industry's most trusted Scientific Advisory Board with over 30 years of Glycemic Index and Science Of Sweetness expertise - that products conform to the strict qualification standards of Glycemic Research Institute® .
​
Glycemic Identity Marks are a glycemic and metabolic impact claim validation labeling system for food and beverage companies who seek to differentiate themselves in the marketplace by building trust and adding value to their consumers' health and shopping experience.
Product(s) Evaluated by Scientific Advisory Board for Claim & Quality Assurance
Certification Standard Report With Evaluation Results Is Generated
Glycemic Identity Marks on Products as a Symbol of Claim & Quality Assurance
What Does the Glycemic Identity Mark (GIM) Mean?
A Glycemic Identity Mark (GIM) confirms and assures that:
-
Product claims have been independently analyzed and evaluated by our Science Advisory Board with over 30 years of experience in the Science of Sweeteness, the glycemic index and that claims adhere to specifications of the Glycemic Research Institute® .
-
Products been independently analyzed and evaluated of foods and beverages, nutritional and nutraceutical products, supplements, educational data (brochures, etc,) functional foods and beverages, sugars, sweeteners, carbohydrates, juice and juice extracts, glycoside sweeteners to determine conformity with Glycemic Research Institute® certification standards.
-
Shows consumers that manufactures and retailers are dedicated to quality, health, and compliance.
-
Offers manufactures and retailers a competitive advantage to the marketplace by differentiating their organization’s commitment to quality, integrity, and compliance.
-
Choosing healthier options is easier for consumers by having a GIM symbol on product labels.
Certification
Programs
The Glycemic Research Institute is an Internationally Accredited Testing & Certification Organization approved by International Governments, including the United States government.
The Glycemic Research Institute Certification Program and Certification Programs are Registered, Authorized, and Licensed by the United States, Canada, and United Kingdom governments, and accepted Worldwide per World Health Organization (WHO) Guidelines.
The Glycemic Research Institute government-issued Certification Marks represent 25-years of Clinical Research in the fields of the Glycemic Index, Diabetes, Cephalic Response, Obesity, Adipose Tissue Fat-Storage, and Childhood Obesity.
The Glycemic Research Institute Certification Marks are legally authorized to make a clinical statement, such as “LOW GLYCEMIC” or ‘DIABETIC FRIENDLY” or “LOW CEPHALIC INDEX” or “KID FRIENDLY” or “NATURAL BEVERAGE” on an FDA label for a commercial food, Nutraceutical, beverage, or Pharmaceutical product.
Any Certification Mark statement representing a clinical claim must be backed by Human In Vivo Clinical Trials per FDA CFR 21 guidelines and per the Clinical Trials Guidelines submitted by the organization licensed to use said Certification Mark.
A Certification Mark on a commercial product legally enables bounding (being under legal obligation) under the following guidelines:
-
The existence of a Legal Product Certification Agreement between the manufacturer of a product and the organization that possesses accreditation by a national government for both testing and product certification.
-
Legal evidence that the product was successfully tested in accordance with a nationally accredited standards.
-
Legal assurance the accredited certification organization has ensured that the item that was successfully tested, and is identical to that which is being offered for sale.
-
Legal assurance that the successful test has resulted in a certification listing, which is considered public information, which sets out the tolerances and conditions of use for the certified product, to enable bounding, and thus compliance with the law.
-
Legal assurance that the manufacturer is being regularly audited by the Certification Organization, at unannounced intervals, to ensure the maintenance of the original process standard that was employed in the manufacture of the test specimen that passed the test, and that if the manufacturer should fail an audit, all product certification, including labels of stock on hand, on construction sites, with end-user customers and on distributor store shelves, shall be immediately removed, and all stakeholders will be informed that the de-listed product certification is no longer eligible for use in bounding.
Quality Assurance
The Legal
Relationship Between
Certifier & Client
Product certification and product qualification is the cornerstone of all bounding for Certification Marks, and the process of certifying that a specific product has passed performance and quality assurance tests or qualification requirements stipulated in regulations and Nationally Accredited Test Standards, and that a product complies with a set of regulations governing quality and/or minimum performance requirements.
On the part of the certifier, in this case, the Glycemic Research Institute® (GRI), is certifying that a product has passed all Clinical Protocols established to use the Glycemic Research Institute® Certification Marks on a label and/or product marketing materials, including websites.
For products that pass the strict Clinical Protocol, the Glycemic Research Institute® allows the use the GRI Mark on the product label, thus indicating legal eligibility of the product for use in bounding, and certifies the origin, material, mode of manufacture of products, mode of performance of services, quality, and accuracy of other characteristics of the product.
Products, once certified, may be endorsed with the Authorized Certification Mark and may be eligible to display said Certification Mark, under the direction and guidelines of the Glycemic Research Institute®.
Trademarks vs
Certification Marks
Trademarks are vastly different from Certification Marks. Trademarks are issued to individuals and companies and represent a word (s) or logo used by that entity.
Certification Marks are difficult to register, and are only issued by the government to companies that are Nationally Accredited Testing and Certification Organizations.
It is difficult, lengthy, and expensive to obtain a Certification Mark from the government, as the organization applying for said Mark must prove worthiness on many different levels of competence, expertise, and good standing in the community.
Companies that are legally issued a Certification Mark must follow strict government guidelines in order to obtain, maintain and continue to use said Marks.
Example of Valid Certification Marks
The main purpose of government Certification Mark regulations is to protect consumers against misleading practices.
Some of the more commonly seen Certification Marks are:
​
​
​
Underwriters Laboratories holds a service mark on the phrase "UL Listed," and allows manufacturers of electrical and other safety equipment to use the UL mark only if they are under follow-up agreement by UL. This lets consumers identify products that meet quality criteria set by a company other than the manufacturer.
​
The Bureau Veritas Certification Mark, used to indicate
the Sea-Worthiness of Ships.
​
​
(U in a full circle), the hechsher of the Orthodox Union.
​
​
Glycemic Research Institute has been conducting Human Clinical In Vivo Trials in the field of diabetes for the past 23 years. This picture represents Nanotechnology in diabetes research.
​
December 2007
Research Stands Up To Intense Scrutiny
UNITED STATES
DEPARTMENT
OF DEFENSE
2008 Department of Defense BUYERS GUIDE
Authorized 2008 Supplier/Vendor:
Listing ID: 2223582873
About the
Glycemic Research Institute
At GRI, we are proud to be a professional clinical research and development organization specializing in glycemic index testing for over 35 years. Our expertise lies in FDA and FTC legal glycemic index claims. We work closely with manufacturers to clearly identify these claims on labels.
Claim Substantiation For:​
Foods
Meals
Prepared Foods Nutraceuticals
Pharmaceuticals and Products in Development​​
We are proud to be
-
Serving the largest food & research companies in the world
-
Board Approved Human In-Vivo Clinical Trials
-
Low Glycemic Index product substantiation
-
Metabolic identity of sugars and sweeteners substantiation
Glycemic Identity Marks
A Symbol Of Quality, Commitment, and Integrity.
The Glycemic Identity Mark (GIM) is a symbol of quality and integrity for consumable products, valued by manufactures, retailers, and consumers. The GIM symbol on a product's label validates its claim, indicating independent evaluation by the industry's trusted Scientific Advisory Board with over 30 years of expertise in Glycemic Index and Science Of Sweetness. This ensures that products conform to the strict quality certification standards of the Glycemic Research Institute.
